Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Silverstein

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The Journal of Urology|May 1, 1992
Idiopathic myelofibrosis with myeloid metaplasia involving the renal pelves, ureters and bladderJ E Oesterling, J P Keating, A J Leroy, et al.
Transactions of the Association of American Physicians|January 1, 1983
Essential thrombocythemia: clinical and laboratory characteristics at presentationH J Iland, J Laszlo, P Peterson, et al.
Cancer|October 1, 1983
Sequential cyclophosphamide-prednisone and vincristine-bleomycin (CPOB). An effective, schedule-dependent treatment for advanced diffuse histiocytic lymphomaG J Johnson, W G Costello, M M Oken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphomaM J O'Connell, D P Harrington, J D Earle, et al.
The New England Journal of Medicine|February 19, 1981
Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapyP D Berk, J D Goldberg, M N Silverstein, et al.
Transactions of the Association of American Physicians|January 1, 1981
Influence of therapy on causes of death in polycythemia veraL R Wasserman, S P Balcerzak, P D Berk, et al.
The American Journal of Medicine|October 1, 1980
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology GroupW D Dewys, C Begg, P T Lavin, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The Journal of Urology|May 1, 1992
Idiopathic myelofibrosis with myeloid metaplasia involving the renal pelves, ureters and bladderJ E Oesterling, J P Keating, A J Leroy, et al.
Transactions of the Association of American Physicians|January 1, 1983
Essential thrombocythemia: clinical and laboratory characteristics at presentationH J Iland, J Laszlo, P Peterson, et al.
Cancer|October 1, 1983
Sequential cyclophosphamide-prednisone and vincristine-bleomycin (CPOB). An effective, schedule-dependent treatment for advanced diffuse histiocytic lymphomaG J Johnson, W G Costello, M M Oken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphomaM J O'Connell, D P Harrington, J D Earle, et al.
The New England Journal of Medicine|February 19, 1981
Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapyP D Berk, J D Goldberg, M N Silverstein, et al.
Transactions of the Association of American Physicians|January 1, 1981
Influence of therapy on causes of death in polycythemia veraL R Wasserman, S P Balcerzak, P D Berk, et al.
The American Journal of Medicine|October 1, 1980
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology GroupW D Dewys, C Begg, P T Lavin, et al.
Pageof 7